In the downloadable article below, our experts highlight the value of performing extractables and leachables (E&L) studies
as early as possible in your medical device and pharmaceutical product development programs.
Traditionally, laboratory studies are not considered as early as they could be, leading to greatly increased risk and potential for significant costs.
Smithers sees there being five clear reasons as to why you should factor E&L programs earlier into your product development plans, and you can explore these in the downloadable article below.
Find out more about Smithers extractables and leachables testing services
, or contact an expert for more information on how we can help.
Download the article below: